News nr. 28 | August 2012
Research and Advanced Education
Print | Send
 | Voltar
Portuguese drug candidate to be developed in China
 
Technophage, a start-up biotech located at Instituto de Medicina Molecular, and the Chinese Shanghai Institute of Materia Medica signed a collaboration agreement to start pre-clinical and clinical tests of a biological product developed by Technophage. TA_101 is a drug candidate for the treatment of inflammatory and autoimmune diseases such as rheumatoid arthritis.

Read more

Source: Institute of Molecular Medicine
Search

Search all of the published newsletters

  SEARCH 

Subscription

Subscribe our Newsletter and receive all the updated information about activities, news, events and other FMUL activities

  

  SEND 

Coordination:
Prof. Doutor J. Fernandes e Fernandes
Editorial Commitee: Prof. Doutor J. Fernandes e Fernandes, Prof. Doutor Alexandre Ribeiro, Prof. Doutor António Vaz Carneiro, Prof. Doutor João Ferreira, Dr. Luis Pereira
Information Officer: Ana Raquel Moreira
Editorial Team: Ana Maria Silva, Ana Raquel Moreira, André Silva, Lara Ponte, Miguel Andrade, Rui Gomes, Sónia Barroso, Susana Henriques, Tânia Simões
Collaboration: Communication and Image Office - Ana Isabel Gonçalves da Silva, Bruno Moura
Design and Technical Support: UTI 
Design and development: Spirituc
e-mail: news@fm.ul.pt